Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: Dependency on levels of pollen exposure

被引：0

作者：

Nolte H. ^{[1
]}

Durham S.R. ^{[2
]}

Nelson H.S. ^{[3
]}

Bernstein D.I. ^{[4
]}

Creticos P. ^{[5
]}

Li Z. ^{[1
]}

Andersen J. ^{[6
]}

Riis B. ^{[6
]}

机构：

[1] Merck and Co., Inc., Whitehouse Station, NJ

[2] Imperial College London, Department of Allergy and Respiratory Medicine, London

[3] National Jewish Health, Departments of Medicine and Pediatrics, Denver, CO

[4] Bernstein Allergy Group, Cincinnati, OH

[5] Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD

[6] ALK-Abelló, Hørsholm

来源：

关键词：

Allergic Rhinitis; Grass Pollen; Pollen Count; Seasonal Allergic Rhinitis; Sublingual Immunotherapy;

D O I：

10.1186/1710-1492-10-S2-A33

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用